{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:44:09Z","timestamp":1778049849651,"version":"3.51.4"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Government of India Department of Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.diabres.2021.108936","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T11:32:48Z","timestamp":1625139168000},"page":"108936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Is diabetes mellitus a wrongdoer to COVID-19 severity?"],"prefix":"10.1016","volume":"178","author":[{"given":"Sanjib","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dibyendu","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sawlang","family":"Borsingh Wann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jatin","family":"Kalita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasenjit","family":"Manna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2021.108936_b0005","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1126\/science.1087139","article-title":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China","volume":"302","author":"Guan","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.diabres.2021.108936_b0010","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1126\/science.1118391","article-title":"Bats are natural reservoirs of SARS-like coronaviruses","volume":"310","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.diabres.2021.108936_b0015","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2021.108936_b0020","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.diabres.2021.108936_b0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.diabres.2021.108936_b0030","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2021.108936_b0035","article-title":"It is Time to Address Airborne Transmission of COVID-19","author":"Morawska","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diabres.2021.108936_b0040","unstructured":"World Health Organization. Coronavirus Disease (COVID-19) Situations Reports. (World Health Organization 2020)."},{"key":"10.1016\/j.diabres.2021.108936_b0045","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/dme.14300","article-title":"COVID-19 and diabetes","volume":"37","author":"Ma","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2021.108936_b0050","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/diacare.26.2.510","article-title":"Quantifying the risk of infectious diseases for people with diabetes","volume":"26","author":"Shah","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2021.108936_b0055","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/431587","article-title":"Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus","volume":"41","author":"Muller","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diabres.2021.108936_b0060","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJM199912163412507","article-title":"Infections in Patients with Diabetes Mellitus","volume":"341","author":"Joshi","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2021.108936_b0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/imm.12394","article-title":"Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections","volume":"144","author":"Hodgson","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.diabres.2021.108936_b0070","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1464-5491.2006.01861.x","article-title":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS","volume":"23","author":"Yang","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2021.108936_b0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12250-015-3679-z","article-title":"Risk factors for severity and mortality in patients with MERS-CoV: Analysis of publicly available data from Saudi Arabia","volume":"31","author":"Banik","year":"2016","journal-title":"Virol Sin"},{"key":"10.1016\/j.diabres.2021.108936_b0080","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2021.108936_b0085","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2021.108936_b0090","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region Italy","volume":"323","author":"Grasselli","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.diabres.2021.108936_b0095","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s40618-020-01236-2","article-title":"Prevalence and impact of diabetes among people infected with SARS-CoV-2","volume":"43","author":"Fadini","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.diabres.2021.108936_b0100","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2021.108936_b0105","doi-asserted-by":"crossref","DOI":"10.1111\/all.14238","article-title":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China","author":"Zhang","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.diabres.2021.108936_b0110","article-title":"Pneumonia in Wuhan, China. JAMA","volume":"2020","author":"Wu","year":"2019","journal-title":"Intern Med"},{"issue":"7","key":"10.1016\/j.diabres.2021.108936_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.diabres.2021.108936_b0120","article-title":"Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis","volume":"2000547","author":"Guan","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.diabres.2021.108936_b0125","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2021.108936_b0130","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet","author":"Yang","year":"2020","journal-title":"Respir Med."},{"key":"10.1016\/j.diabres.2021.108936_b0135","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.2337\/dc20-1506","article-title":"Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19","volume":"43","author":"Seiglie","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2021.108936_b0140","first-page":"1775","article-title":"Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy","volume":"323","author":"Onder","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2021.108936_b0145","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.2337\/dc20-0598","article-title":"Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center","volume":"43","author":"Shi","year":"2020","journal-title":"Retrospective Study. Diabetes Care"},{"key":"10.1016\/j.diabres.2021.108936_b0150","doi-asserted-by":"crossref","unstructured":"Petrilli CM, Jones SA, Yang J, Rajagopalan H, O'Donnell LF, Chernyak Y, et al. Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City. medRxiv. 2020:2020.04.08.20057794.","DOI":"10.1101\/2020.04.08.20057794"},{"key":"10.1016\/j.diabres.2021.108936_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2020.04.021","article-title":"Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes","volume":"31","author":"Zhu","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.diabres.2021.108936_b0160","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2021.108936_b0165","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4093\/dmj.2020.0146","article-title":"The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu","volume":"44","author":"Kim","year":"2020","journal-title":"South Korea. Diabetes Metab J"},{"key":"10.1016\/j.diabres.2021.108936_b0170","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/jmv.25783","article-title":"Clinical features and treatment of COVID-19 patients in northeast Chongqing","volume":"92","author":"Wan","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.diabres.2021.108936_b0175","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMsa2011686","article-title":"Hospitalization and Mortality among Black Patients and White Patients with Covid-19","volume":"382","author":"Price-Haywood","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2021.108936_b0180","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2337\/dc20-1444","article-title":"Type 2 Diabetes and COVID-19\u2013Related Mortality in the Critical Care Setting: A National Cohort Study in England, March\u2013July 2020","volume":"44","author":"Dennis","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2021.108936_b0185","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1001\/jama.2020.7202","article-title":"Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California","volume":"323","author":"Myers","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2021.108936_b0190","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","author":"Shang","year":"2020","journal-title":"Nature"},{"issue":"271\u201380","key":"10.1016\/j.diabres.2021.108936_b0195","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.diabres.2021.108936_b0200","doi-asserted-by":"crossref","unstructured":"Zhou L, Niu Z, Jiang X, Zhang Z, Zheng Y, Wang Z, et al. Systemic analysis of tissue cells potentially vulnerable to SARS-CoV-2 infection by the protein-proofed single-cell RNA profiling of ACE2, TMPRSS2 and Furin proteases. bioRxiv. 2020:2020.04.06.028522.","DOI":"10.1101\/2020.04.06.028522"},{"key":"10.1016\/j.diabres.2021.108936_b0205","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","volume":"26","author":"Sungnak","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.diabres.2021.108936_b0210","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41368-020-0074-x","article-title":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa","volume":"12","author":"Xu","year":"2020","journal-title":"Int J Oral Sci"},{"key":"10.1016\/j.diabres.2021.108936_b0215","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.2337\/db10-1205","article-title":"ACE2 and diabetes: ACE of ACEs?","volume":"59","author":"Batlle","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2021.108936_b0220","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1042\/CS20130344","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications","volume":"126","author":"Patel","year":"2014","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.diabres.2021.108936_b0225","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1053\/j.ajkd.2007.11.022","article-title":"Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls","volume":"51","author":"Mizuiri","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabres.2021.108936_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108132","article-title":"COVID-19, diabetes mellitus and ACE2: The conundrum","volume":"162","author":"Pal","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2021.108936_b0235","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.2337\/db20-0669","article-title":"Expression of ACE2, the SARS-CoV-2 Receptor, in Lung Tissue of Patients With Type 2 Diabetes","volume":"69","author":"Wijnant","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2021.108936_b0240","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2021.108936_b0245","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bcp.2017.07.022","article-title":"Azilsartan ameliorates diabetic cardiomyopathy in young db\/db mice through the modulation of ACE-2\/ANG 1\u20137\/Mas receptor cascade","volume":"144","author":"Sukumaran","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.diabres.2021.108936_b0250","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1042\/CS20120162","article-title":"Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions","volume":"123","author":"Burchill","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.diabres.2021.108936_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.diabres.2021.108936_b0260","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19","volume":"382","author":"Reynolds","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2021.108936_b0265","doi-asserted-by":"crossref","unstructured":"Mancia G, Rea F. Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19. 2020;382:2431-40.","DOI":"10.1056\/NEJMoa2006923"},{"key":"10.1016\/j.diabres.2021.108936_b0270","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taaa041","article-title":"Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19","author":"Diaz","year":"2020","journal-title":"J Travel Med."},{"key":"10.1016\/j.diabres.2021.108936_b0275","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-2600(20)30558-0","article-title":"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial","volume":"9","author":"Cohen","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.diabres.2021.108936_b0280","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/jama.2020.25864","article-title":"Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial","volume":"325","author":"Lopes","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2021.108936_b0285","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.596898","article-title":"SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic \u03b2-Cells and in the Human Pancreas Microvasculature","volume":"11","author":"Fignani","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.diabres.2021.108936_b0290","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cmet.2020.11.005","article-title":"Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19","volume":"32","author":"Kusmartseva","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.diabres.2021.108936_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2020.11.006","article-title":"SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in \u03b2 Cells","volume":"32","author":"Coate","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.diabres.2021.108936_b0300","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00592-009-0109-4","article-title":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes","volume":"47","author":"Yang","year":"2010","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.diabres.2021.108936_b0305","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/dom.14269","article-title":"Proportion of newly diagnosed diabetes in COVID-19 patients: A systematic review and meta-analysis","volume":"23","author":"Sathish","year":"2021","journal-title":"Diabetes, Obes Metab"},{"key":"10.1016\/j.diabres.2021.108936_b0310","article-title":"Diabetes is a risk factor for the progression and prognosis of COVID-19","author":"Guo","year":"20203319","journal-title":"Diabetes Metab Res Rev."},{"key":"10.1016\/j.diabres.2021.108936_b0315","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/cen.14288","article-title":"COVID-19 and diabetes: Insulin requirements parallel illness severity in critically unwell patients","volume":"93","author":"Wu","year":"2020","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.diabres.2021.108936_b0320","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 2","key":"10.1016\/j.diabres.2021.108936_b0325","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.2337\/dc08-s243","article-title":"Islet inflammation in type 2 diabetes: from metabolic stress to therapy","volume":"31","author":"Donath","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2021.108936_b0330","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ni.1935","article-title":"Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1\u03b2 in type 2 diabetes","volume":"11","author":"Masters","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.diabres.2021.108936_b0335","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.diabres.2021.108936_b0340","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41419-017-0135-z","article-title":"Cellular death, reactive oxygen species (ROS) and diabetic complications","volume":"9","author":"Volpe","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.diabres.2021.108936_b0345","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.2337\/diab.43.9.1122","article-title":"Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia","volume":"43","author":"Xia","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2021.108936_b0350","article-title":"Role of c-Jun N-terminal Kinase (JNK) in Obesity and Type 2 Diabetes","volume":"9","author":"Yung","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.diabres.2021.108936_b0355","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clim.2018.06.003","article-title":"Effect of high glucose on cytokine production by human peripheral blood immune cells and type I interferon signaling in monocytes: Implications for the role of hyperglycemia in the diabetes inflammatory process and host defense against infection","volume":"195","author":"Hu","year":"2018","journal-title":"Clinical Immunol"},{"key":"10.1016\/j.diabres.2021.108936_b0360","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/920613","article-title":"Cytokines and diabetes research","author":"Xiao","year":"2014","journal-title":"J Diabetes Res."},{"key":"10.1016\/j.diabres.2021.108936_b0365","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2796.2000.00705.x","article-title":"Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors","volume":"248","author":"Lechleitner","year":"2000","journal-title":"J Intern Med."},{"key":"10.1016\/j.diabres.2021.108936_b0370","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1007\/s001250050822","article-title":"NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X","volume":"40","author":"Pickup","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2021.108936_b0375","article-title":"Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States","volume":"1932296820924469","author":"Bode","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabres.2021.108936_b0380","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fmicb.2019.00050","article-title":"Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome","volume":"10","author":"Chen","year":"2019","journal-title":"Front Microbiol."},{"key":"10.1016\/j.diabres.2021.108936_b0385","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1128\/IAI.73.4.1907-1916.2005","article-title":"Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells","volume":"73","author":"Fink","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.diabres.2021.108936_b0390","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1128\/JVI.02576-13","article-title":"Inhibition of NF-\u03baB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival","volume":"88","author":"DeDiego","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.diabres.2021.108936_b0395","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3389\/fimmu.2016.00366","article-title":"Neutrophil Extracellular Traps Go Viral","volume":"7","author":"Schonrich","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.diabres.2021.108936_b0400","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200652","article-title":"Targeting potential drivers of COVID-19: Neutrophil extracellular traps","volume":"217","author":"Barnes","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.diabres.2021.108936_b0405","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.4049\/jimmunol.1201719","article-title":"Neutrophil extracellular traps: double-edged swords of innate immunity","volume":"189","author":"Kaplan","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.diabres.2021.108936_b0410","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nm.3887","article-title":"Diabetes primes neutrophils to undergo NETosis, which impairs wound healing","volume":"21","author":"Wong","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.diabres.2021.108936_b0415","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.4049\/jimmunol.1002615","article-title":"Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes","volume":"186","author":"Jagannathan-Bogdan","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.diabres.2021.108936_b0420","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/cid\/ciy595","article-title":"Immune Responses to Middle East Respiratory Syndrome Coronavirus During the Acute and Convalescent Phases of Human Infection","volume":"68","author":"Shin","year":"2019","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.diabres.2021.108936_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.diabres.2021.108936_b0430","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00125-010-1730-z","article-title":"Toll-like receptors regulate B cell cytokine production in patients with diabetes","volume":"53","author":"Jagannathan","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2021.108936_b0435","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1016\/j.bbadis.2018.05.012","article-title":"GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms","volume":"1864","author":"Rizzo","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.diabres.2021.108936_b0440","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1089\/met.2017.0057","article-title":"Mast Cell and M1 Macrophage Infiltration and Local Pro-Inflammatory Factors Were Attenuated with Incretin-Based Therapies in Obesity-Related Glomerulopathy","volume":"15","author":"He","year":"2017","journal-title":"Metab Syndr Relat Disord."},{"key":"10.1016\/j.diabres.2021.108936_b0445","article-title":"Letter to the editor in response to the article \u201cCOVID-19 and diabetes: Can DPP4 inhibition play a role?\u201d","author":"Kokic","year":"2020","journal-title":"Diabetes Res Clin Pract."},{"key":"10.1016\/j.diabres.2021.108936_b0450","first-page":"1613","article-title":"Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2","volume":"2014","author":"Wronkowitz","year":"1842","journal-title":"Biochim et Biophys Acta (BBA) - Molecular Basis Dis"},{"key":"10.1016\/j.diabres.2021.108936_b0455","first-page":"E3119","article-title":"Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice","volume":"114","author":"Li","year":"2017","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.diabres.2021.108936_b0460","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2337\/dc20-1521","article-title":"Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective","volume":"43","author":"Solerte","year":"2020","journal-title":"Observational Study. Diabetes Care."},{"key":"10.1016\/j.diabres.2021.108936_b0465","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.2337\/dc20-1340","article-title":"Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy","volume":"43","author":"Mirani","year":"2020","journal-title":"Italy. Diabetes Care."},{"key":"10.1016\/j.diabres.2021.108936_b0470","article-title":"Use of dipeptidyl peptidase-4 inhibitors and prognosis of COVID-19 in hospitalized patients with type 2 diabetes: A propensity score analysis from the CORONADO study","volume":"1\u201311","author":"Roussel","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2021.108936_b0475","doi-asserted-by":"crossref","unstructured":"Israelsen SB, Pottegard A. Comparable COVID-19 outcomes with current use of GLP-1 receptor agonists, DPP-4 inhibitors or SGLT-2 inhibitors among patients with diabetes who tested positive for SARS-CoV-2. 2021.","DOI":"10.1111\/dom.14329"},{"key":"10.1016\/j.diabres.2021.108936_b0480","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S2213-8587(21)00050-4","article-title":"Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England","volume":"9","author":"Khunti","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2021.108936_b0485","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2021.108936_b0490","doi-asserted-by":"crossref","unstructured":"Wiernsperger NF, Bailey CJ. The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms. Drugs. 1999;58 Suppl 1:31-9; discussion 75\u201382.","DOI":"10.2165\/00003495-199958001-00009"},{"key":"10.1016\/j.diabres.2021.108936_b0495","first-page":"1166","article-title":"Metformin Use in Diabetes Prior to Hospitalization: Effects on Mortality in Covid-19","volume":"26","author":"Li","year":"2020","journal-title":"Endocrinepractice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists."},{"key":"10.1016\/j.diabres.2021.108936_b0500","doi-asserted-by":"crossref","unstructured":"Crouse A, Grimes T, Li P, Might M, Ovalle F, Shalev A. Metformin Use is Associated with Reduced Mortality in a Diverse Population wth COVID-19 and Diabetes. medRxiv. 2020:2020.07.29.20164020.","DOI":"10.1101\/2020.07.29.20164020"},{"key":"10.1016\/j.diabres.2021.108936_b0505","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4269\/ajtmh.20-0375","article-title":"Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis","volume":"103","author":"Luo","year":"2020","journal-title":"Am J Trop Med Hyg."},{"key":"10.1016\/j.diabres.2021.108936_b0510","article-title":"Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study","volume":"173","author":"Chen","year":"2020","journal-title":"Diabetes Res Clin Pract."},{"key":"10.1016\/j.diabres.2021.108936_b0515","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgab067","article-title":"Association of metformin with susceptibility to COVID-19 in people with Type 2 diabetes","author":"Wang","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.diabres.2021.108936_b0520","doi-asserted-by":"crossref","unstructured":"Bramante CT, Ingraham NE, Murray TA, Marmor S, Hovertsen S, Gronski J, et al. Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19. medRxiv. 2020:2020.06.19.20135095.","DOI":"10.1101\/2020.06.19.20135095"},{"key":"10.1016\/j.diabres.2021.108936_b0525","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/S2666-7568(20)30033-7","article-title":"Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis","volume":"2","author":"Bramante","year":"2021","journal-title":"Lancet Healthy longevity."},{"key":"10.1016\/j.diabres.2021.108936_b0530","unstructured":"Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, et al. The feasibility of convalescent plasma therapy in severe COVID-19 patients: a pilot study. medRxiv. 2020:2020.03.16.20036145."},{"key":"10.1016\/j.diabres.2021.108936_b0535","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1473-3099(20)30141-9","article-title":"Convalescent plasma as a potential therapy for COVID-19","volume":"20","author":"Chen","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diabres.2021.108936_b0540","article-title":"Anti-inflammatory properties of antidiabetic drugs: A \u201cpromised land\u201d in the COVID-19 era?","volume":"34","author":"Katsiki","year":"2020","journal-title":"J Diabetes Complicats."}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721002965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822721002965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:16:53Z","timestamp":1759173413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822721002965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":108,"alternative-id":["S0168822721002965"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2021.108936","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is diabetes mellitus a wrongdoer to COVID-19 severity?","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2021.108936","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108936"}}